ZGD-28773-46987
4 vaccinations
4 coded responses
27 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 774 / TX
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Dose 1 — Moderna
-
2021-01-16
Registered in v-safe
-
2021-01-16
Survey response — days 1–6 daily, dose 1MedDRA: Insomnia — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: InsomniaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-01-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
-
2021-01-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-01-22
- 2021-01-29
- 2021-02-05
-
2021-02-12
Dose 2 — Moderna
- 2021-02-19
- 2021-02-28
- 2021-03-12
- 2021-03-19
- 2021-03-26
-
2021-05-19
Survey response — 3 months, dose 2MedDRA: Gastroenteritis viral, Nasopharyngitis — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Common cold + stomach virus (I teach second grade, so I'm exposed to a lot)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-13
-
2021-09-11
Dose 3 — Moderna
- 2021-10-25
- 2021-12-11
- 2022-03-12
-
2022-10-14
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-15
- 2022-10-16
- 2022-10-18
- 2022-10-23
-
2022-10-28
Survey response — day 14, dose 4MedDRA: Viral upper respiratory tract infection — Feeling: GoodFree text: Upper respiratory virusMedDRA releases: 2024-11 · check-in free text available
-
2022-11-04
Survey response — day 21, dose 4MedDRA: Nasopharyngitis — Feeling: GoodFree text: On my third cold in 3 months #teacherproblemsMedDRA releases: 2024-11 · check-in free text available
- 2022-11-13
- 2022-11-20
- 2022-11-25
- 2023-01-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2021-09-11 | Moderna | No |
| 4 | 2022-10-14 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-16 | priority 2/3 |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Insomnia
Release 8 — 3 months, dose 2
Symptoms: Common cold + stomach virus (I teach second grade, so I'm exposed to a lot)
Release 12 — day 14, dose 4
Symptoms: Upper respiratory virus
Release 12 — day 21, dose 4
Symptoms: On my third cold in 3 months #teacherproblems
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastroenteritis viral | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Viral upper respiratory tract infection | · | · | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release